DYNT - Dynatronics Corp. Average Forecast Price

Corporate company logo of Dynatronics Corporation (DYNT)

Dynatronics Corporation (DYNT) success relies on product line updates coupled with cost control, while current liquidity is recorded at 0.00. The company develops durable rehabilitation devices by integrating material recycling principles into production. The price indicator on this chart confirms the resilience of the physical therapy equipment business, where high clinic demand and significant product profitability ensure a stable inflow of free cash flow.

DYNT (Dynatronics Corporation) Consensus Target history from 07/04/2022 to 08/04/2024
Core merchandise of Dynatronics Corporation

This indicator reflects the aggregated expectations of institutional experts, assessing the sensitivity of business value to changes in discount rates and the cost of capital. The investor analyzes the trajectory of analysts' target prices to determine the fair valuation of Dynatronics Corporation (DYNT), considering the stable demand for rehabilitation equipment and the potential for updating thermotherapy system product lines within a mature market.

Competing companies

bostonscientific.com - Broker Consensus Forecast|Edwards Lifesciences Corporation - Consensus Target|ResMed Inc (RMD) - Average Forecast Price|PODD - Price Target Chart|ZBH (Zimmer Biomet Corp) - Broker Consensus Forecast|COO (The Cooper Companies) - Consensus Target|ALGN: Analyst Forecast Prices|Price Target Chart Globus Medical|TransMedics (TMDX) - Analyst Median Target|Price Target Chart ATEC Spine (ATEC)|AORT: Forecast Levels Chart|Analyst Consensus Forecast ENOV (Enovis Corporation)|integralife.com (IART) - Average Forecast Price|Establishment Labs Holdings Inc. - Analyst Consensus Forecast|Beta Bionics, Inc. (BBNX) - Consensus Target|IRMD: Analyst Consensus Forecast|EMBC - Analyst Median Target|TNDM (Tandem Diabetes Care) - Analyst Consensus Forecast|Analyst Consensus Forecast axogeninc.com|Price Target Chart SI-BONE (SIBN)|Price Target Chart OFIX (Orthofix Medical)|Analyst Consensus Forecast BVS (Bioventus Corp)|Analyst Median Target OrthoPediatrics Corp (KIDS)|TMCI: Consensus Target|Forecast Levels Chart SRTA|CARL: Analyst Consensus Forecast|Average Forecast Price RxSight Inc (RXST)|CLPT (ClearPoint Neuro Inc.) - Analyst Consensus Forecast|Broker Consensus Forecast STXS (Stereotaxis Corporation)|Consensus Target STIM (Neuronetics, Inc.)|SGHT (sightsciences.com) - Fair Value Consensus|Price Target Chart Orchestra BioMed OBIO|ANIK - Consensus Target|InspireMD Corp - Analyst Consensus Forecast|Average Forecast Price Jin Medical International|VANI: Analyst Consensus Forecast|Broker Consensus Forecast XTNT|NMTC (NeuroOne Medical Technologies Corporation) - Analyst Consensus Forecast|Modular Med (MODD) - Analyst Median Target|Analyst Consensus Forecast MYO|Consensus Target Envoy Medical Inc COCH|Analyst Consensus Forecast VVOS (Vivos Therapeutics)|Analyst Consensus Forecast envveno.com NVNO|SINT - Price Target Chart|TNON: Price Target Chart|LFWD (ReWalk Robotics Ltd) - Consensus Target|Autonomix Medical - Fair Value Consensus|IVF (INVO Fertility Inc) - Analyst Consensus Forecast|Average Forecast Price bonebiologics.com BBLG|Price Target Chart Axonics (AXNX)|BIOLASE Inc. (BIOL) - Analyst Target Range|Paragon 28 - Consensus Target|Analyst Consensus Forecast INVO Bioscience Inc. INVO